Vimarsana
Biggest News Aggregation in the World

Page 2 - Lysosomal Storage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lysosomal Storage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lysosomal Storage Today - Breaking & Trending Today

Astellas Announces Update on Preliminary Safety and Efficacy Data from FORTIS Study of Investigational AT845 in Adults with Late-Onset Pompe Disease - Vimarsana News

Astellas Announces Update on Preliminary Safety and Efficacy Data from FORTIS Study of Investigational AT845 in Adults with Late-Onset Pompe Disease

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced an update on preliminary safety and...

Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease - Vimarsana News

Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the U.S. Food and Drug...

No patient with rare disease has benefitted from Centre's policy that assures financial help: BJP MP - Vimarsana News

No patient with rare disease has benefitted from Centre's policy that assures financial help: BJP MP

Varun Gandhi was referring to the National Policy for Rare Diseases aimed at helping families from prohibitively high expenses for treating rare diseases.

Source: scroll.in
Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102 - Vimarsana News

Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102

Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102 - read this article along with other careers information, tips and advice on BioSpace

Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102 - Vimarsana News

Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and...